鶹ýӰ

Meeting Coverage

ACTRIMS

Americas Committee for Treatment and Research in Multiple Sclerosis

BTK Inhibitor Fails to Eliminate Paramagnetic Rim Lesions in MS

Higher tolebrutinib dose, longer treatment duration may be needed

ACTRIMS over a photo of Palm Beach County Convention Center in West Palm Beach, FL

Latest ACTRIMS Meeting Coverage

Evobrutinib Fails to Beat Teriflunomide in Relapsing MS

No efficacy difference between the two drugs in two phase III trials

March 6, 2024
Cognitive Decline in MS Predicted by Paramagnetic Rim Lesions

Processing speed scores lower 4 years later for people with one or more baseline lesions

March 4, 2024
Ozanimod Controls MS Disease Activity Regardless of Age

Clinical, radiologic measures remained stable or improved in both younger and older patients

March 3, 2024
Long COVID May Be Difficult to Identify in MS

Tough to pinpoint what is a long-term MS symptom and what is a long COVID symptom

March 2, 2024
Obesity Associated With Faster MS Disease Progression

Increased risk of physical, psychological, cognitive decline

March 2, 2024
MS Patients on Cladribine Show Fewer Relapses

Real-world data analysis compares oral disease-modifying therapies

March 1, 2022
Stem Cell Transplantation Shows Benefits in Aggressive MS

No new relapses recorded after autologous transplant

February 28, 2022
Deep Learning Identifies PPMS Patients Who May Respond to Treatment

Predictive enrichment could increase the power of future trials

February 27, 2022
Paramagnetic Rim Lesions Highly Specific in MS Diagnosis

Sensitivity, accuracy also high in prospective study

February 26, 2022
Cervical Cord Atrophy Predicts Silent MS Progression

Ventricular enlargement was second strongest indicator

February 26, 2022
COVID Vax Response Still Impaired in Some MS Patients After Third Shot

Subset of multiple sclerosis patients seroconverted after third dose, however

February 25, 2022
Real-World Study Shows MS Patients Have High Infection Risks

Urinary, kidney infections especially are more common for people with MS than others

March 2, 2021
Juggling COVID Vax, MS Therapies Proves Challenging

The issue: some multiple sclerosis drugs may attenuate antibody responses to vaccination

March 1, 2021
Worse COVID-19 Outcomes Tied to MS Disability, Age

North American data echoes findings from around the world

February 28, 2021